Ping Ling

2.4k total citations
17 papers, 2.0k citations indexed

About

Ping Ling is a scholar working on Immunology, Physiology and Immunology and Allergy. According to data from OpenAlex, Ping Ling has authored 17 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Physiology and 3 papers in Immunology and Allergy. Recurrent topics in Ping Ling's work include Mast cells and histamine (4 papers), Asthma and respiratory diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Ping Ling is often cited by papers focused on Mast cells and histamine (4 papers), Asthma and respiratory diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Ping Ling collaborates with scholars based in United States, China and Switzerland. Ping Ling's co-authors include Maurice K. Gately, Robin L. Thurmond, M K Warren, S N Vogel, Emil R. Unanue, Jalil Hakimi, Catherine S. Tripp, Rob Leurs, Herman D. Lim and Remko A. Bakker and has published in prestigious journals such as The Journal of Immunology, Infection and Immunity and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ping Ling

17 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Ling United States 14 1.3k 465 304 239 210 17 2.0k
Michel Dy France 26 2.3k 1.8× 732 1.6× 304 1.0× 235 1.0× 165 0.8× 48 3.0k
Masako Murai Japan 20 1.8k 1.4× 605 1.3× 281 0.9× 214 0.9× 305 1.5× 33 2.8k
Jane S.A. Voerman Netherlands 19 2.3k 1.8× 670 1.4× 433 1.4× 133 0.6× 195 0.9× 35 3.3k
J I Gallin United States 22 967 0.7× 636 1.4× 264 0.9× 320 1.3× 202 1.0× 25 2.0k
Yumi Yamashita Japan 26 1.1k 0.9× 934 2.0× 166 0.5× 126 0.5× 232 1.1× 77 2.3k
Nancy D. Kim United States 15 1.0k 0.8× 850 1.8× 270 0.9× 233 1.0× 81 0.4× 18 2.3k
Stephen H. Benedict United States 27 664 0.5× 503 1.1× 183 0.6× 215 0.9× 117 0.6× 76 1.8k
Héctor Martínez-Valdez United States 23 1.1k 0.9× 747 1.6× 136 0.4× 74 0.3× 169 0.8× 48 2.2k
Takeshi Kono Japan 18 1.1k 0.8× 538 1.2× 131 0.4× 264 1.1× 103 0.5× 56 2.1k
Joel Tocker United States 21 1.7k 1.3× 259 0.6× 620 2.0× 206 0.9× 185 0.9× 32 2.3k

Countries citing papers authored by Ping Ling

Since Specialization
Citations

This map shows the geographic impact of Ping Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Ling more than expected).

Fields of papers citing papers by Ping Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Ling. The network helps show where Ping Ling may publish in the future.

Co-authorship network of co-authors of Ping Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Ling. A scholar is included among the top collaborators of Ping Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Ling. Ping Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ling, Ping, Yongwen Zhou, Jing Lv, et al.. (2024). Correlation between triglyceride-glucose index and diabetic kidney disease risk in adults with type 1 diabetes mellitus. Diabetology & Metabolic Syndrome. 16(1). 239–239. 4 indexed citations
2.
Hou, Dezhi, et al.. (2023). Therapeutic properties, biological effects, antiliver cancer, and anticolon cancer effects of some natural compounds: A biochemical approach. Journal of Biochemical and Molecular Toxicology. 38(1). e23573–e23573. 4 indexed citations
3.
Ling, Ping, et al.. (2021). miR‑1184 regulates inflammatory responses and cell apoptosis by targeting TRADD in an LPS‑induced cell model of sepsis. Experimental and Therapeutic Medicine. 21(6). 630–630. 10 indexed citations
4.
Ouyang, Yiming, Linhai Li, & Ping Ling. (2020). Nobiletin Inhibits Helicobacterium pylori Infection-Induced Gastric Carcinogenic Signaling by Blocking Inflammation, Apoptosis, and Mitogen-Activated Protein Kinase Events in Gastric Epithelial-1 Cells. Journal of Environmental Pathology Toxicology and Oncology. 39(1). 77–88. 20 indexed citations
5.
Zhang, Jian, Jingyuan Li, Weimin Bao, et al.. (2019). Effects of high‐fat diet‐induced adipokines and cytokines on colorectal cancer development. FEBS Open Bio. 9(12). 2117–2125. 17 indexed citations
6.
7.
Cowden, Jeffery M., Fuqu Yu, Homayon Banie, et al.. (2013). The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Annals of the Rheumatic Diseases. 73(3). 600–608. 50 indexed citations
8.
Lim, Herman D., Richard M. van Rijn, Ping Ling, et al.. (2005). Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1310–1321. 242 indexed citations
9.
Ling, Ping, Karen Ngo, Steven Nguyen, et al.. (2004). Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. British Journal of Pharmacology. 142(1). 161–171. 214 indexed citations
10.
Fung‐Leung, Wai‐Ping, Robin L. Thurmond, Ping Ling, & Lars Karlsson. (2004). Histamine H4 receptor antagonists: the new antihistamines?. PubMed. 5(11). 1174–83. 33 indexed citations
11.
D’Andrea, Michael R., Claudia K. Derian, Didier Leturcq, et al.. (1998). Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues. Journal of Histochemistry & Cytochemistry. 46(2). 157–164. 288 indexed citations
12.
Gillessen, Silke, Daisy Carvajal, Ping Ling, et al.. (1995). Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist. European Journal of Immunology. 25(1). 200–206. 391 indexed citations
13.
Tahan, Steven R., et al.. (1995). Influence of formalin fixation time and tissue processing method on immunoreactivity of monoclonal antibody PC10 for proliferating cell nuclear antigen.. PubMed. 8(2). 177–82. 14 indexed citations
14.
Tripp, Catherine S., Maurice K. Gately, Jalil Hakimi, Ping Ling, & Emil R. Unanue. (1994). Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.. The Journal of Immunology. 152(4). 1883–1887. 271 indexed citations
15.
Heinzel, Frederick P., Ronald M. Rerko, Ping Ling, J Hakimi, & David S. Schoenhaut. (1994). Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infection and Immunity. 62(10). 4244–4249. 197 indexed citations
16.
17.
Ling, Ping, M K Warren, & S N Vogel. (1985). Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.. The Journal of Immunology. 135(3). 1857–1863. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026